NCT03064438View on ClinicalTrials.gov

Safety and Efficacy of ACU-D1 in the Treatment of Acne Rosacea

PHASE2CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

November 28, 2017

Primary Completion Date

June 5, 2018

Study Completion Date

June 18, 2018

Conditions

Acne Rosacea

Interventions

DRUG

ACCU-D1

ACCU-D1

DRUG

Vehicle

Placebo Comparator

Trial Locations (2)

40421

DS Research, Louisville

78759

DermResearch, Austin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Accuitis, Inc.

INDUSTRY